Insider Selling: Trupanion (NASDAQ:TRUP) CEO Sells $28,410.90 in Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 978 shares of Trupanion stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total transaction of $28,410.90. Following the sale, the chief executive officer owned 175,401 shares of the company’s stock, valued at approximately $5,095,399.05. This represents a 0.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

• On Monday, May 25th, Margaret Tooth sold 491 shares of Trupanion stock. The shares were sold at an average price of $21.86, for a total value of $10,733.26.

Trupanion Price Performance

TRUP stock opened at $30.60 on Friday. The company has a market capitalization of $1.34 billion, a PE ratio of 57.74, a P/E/G ratio of 2.20 and a beta of 1.39. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The business’s fifty day moving average price is $25.56 and its 200 day moving average price is $26.11. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $49.90.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The company had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. During the same period in the prior year, the firm earned $0.22 earnings per share. The business’s revenue for the quarter was up 11.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Trupanion, Inc. will post 0.59 EPS for the current year.

Institutional Trading of Trupanion

Several institutional investors and hedge funds have recently modified their holdings of the business. Thrivent Financial for Lutherans grew its holdings in Trupanion by 1.1% during the 2nd quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock valued at $1,376,000 after buying an additional 282 shares during the last quarter. EP Wealth Advisors LLC boosted its position in shares of Trupanion by 2.9% in the second quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock worth $571,000 after acquiring an additional 292 shares during the last quarter. Illinois Municipal Retirement Fund grew its stake in shares of Trupanion by 2.3% during the 1st quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock valued at $456,000 after buying an additional 406 shares during the period. Price T Rowe Associates Inc. MD grew its position in Trupanion by 2.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider’s stock valued at $1,258,000 after acquiring an additional 725 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Trupanion by 3.8% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after purchasing an additional 737 shares during the period.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Stifel Nicolaus set a $28.00 price objective on Trupanion in a research note on Friday, June 26th. Weiss Ratings raised shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday. Finally, Atlantic Securities set a $42.00 price target on Trupanion in a report on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $41.60.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.